Please login to the form below

pemetrexed disodium

This page shows the latest pemetrexed disodium news and features for those working in and with pharma, biotech and healthcare.

Lilly wins on appeal in Alimta vitamin regimen dispute

The ruling finds that Actavis generics on sale in the UK, France, Italy and Spain infringe on Lilly's patents for Alimta (pemetrexed disodium), which has lost patent protection in several ... The compound patent on pemetrexed disodium expired in December

Latest news

Lilly’s president and chief executive John Lechleiter to retire

Sales of blockbuster lung cancer treatment Alimta (pemetrexed disodium) have suffered with UK and German courts ruling in favour of the generic competition, while patents for Lilly's osteoporosis drug Evista
UK court backs Actavis in dispute over Lilly's Alimta

The UK High Court has ruled that a patent held by Lilly on a vitamin regimen for Alimta (pemetrexed disodium) - a series of vitamin B12 injections used to reduce the ... The compound patent on pemetrexed disodium expired in December 2015 in most European
German court overturns patent on Lilly blockbuster Alimta

The patent challenge was not for the compound patent on pemetrexed disodium - the active ingredient in Alimta - but for a vitamin regimen used alongside the drug that is designed to limit ... The generic drugmaker is developing a different salt for of

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Account Manager / Account Director: Competative

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Account Manager / Senior Account Manager: 35, 000-40, 000

Director, Market Access / HEOR - North-West: Negotiable

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Senior Medical Writer (Remote Working): Competitive Salary Offered

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Consultant Health Economics - London / Oxford: Negotiable

Senior Systematic Review Analyst - Oxford: Negotiable

Associate Director, Market Access & HEOR – North-West: Negotiable

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Medical/ Scientific Director: Salary TBC

Client Services Director – Medical Education Agency – North West...: Salary TBC

Account Director: Excellent benefits

Medical Writers: Competitive Salary and Benefits

Senior Account Executive, London, Medical Communications: Excellent package

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Senior Medical Writer: Great salary and benefits

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Events Manager – Med Comms – Surrey: Salary TBC

Account Director: £48, 000 - £60, 000

Subscribe to our email news alerts

PMHub

Add my company

Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...